Relative contribution of different vascular beds to the pressor effects of alpha-adrenoreceptor agonists and vasopressin in pithed rats: radioactive microsphere determination.
The relative fractional distribution of 51Cr-labelled microspheres was evaluated in pithed rats during equieffective vascoconstrictor responses evoked by infusions of the alpha-adrenoreceptor agonists methoxamine (alpha 1-selective), UK-14,304 (alpha 2-selective) or vasopressin. The proportion of injected radioactive microspheres trapped in each tissue during a sustained pressor response relative to saline treated controls is considered a reflection of the degree of local vascoconstriction in the tissue analysed. All three agonists (methoxamine, UK-14,304 and vasopressin) decreased the number of microspheres trapped in the mesentery and tail. Only methoxamine reduced the blood flow to the kidney and spleen. UK-14,304 did not modify the number of microspheres in the sample of skeletal muscle, however, both vasopressin and methoxamine reduced the blood flow to this tissue. Vasopressin increased the counts in the lungs and particularly in the liver but decreased the number of spheres trapped in the stomach and skin. In contrast to the alpha-adrenoreceptor agonists, vasopressin did not increase the number of microspheres trapped in the heart. Since a reduction in the number of microspheres trapped in the tissue reflects a decrease in blood flow, to that organ it is reasonable to conclude that alpha 1-adrenoreceptor stimulation increases kidney, spleen, mesentery, caudal and skeletal muscle vascular resistance, whereas alpha 2-adrenoreceptors appear to preferentially vasoconstrict the mesenteric and the caudal vascular beds.
Waldron
C J
CJ
Hicks
P E
PE
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D000068438:Brimonidine Tartrate; D002860:Chromium Radioisotopes; D003655:Decerebrate State; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D008863:Microspheres; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014661:Vasoconstriction / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D002860:Chromium Radioisotopes; D011810:Quinoxalines; D014667:Vasopressins; D000068438:Brimonidine Tartrate; D008729:Methoxamine